CIK 1537607
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2024-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
| Name | Title (as filed) | Since | Ownership |
|---|---|---|---|
| AUGUST, GLENN, RUSSELL | FOUNDER/CHIEF EXECUTIVE OFFICER | 1999-08 | <5% ·◆ |
| Atteslis, Alexis, NMN | UK MANAGEMENT COMMITTEE | 2019-12 | <5% ·◆ |
| BOHNSACK, WILLIAM, HARTWIG | PRESIDENT/SENIOR PARTNER | 2001-01 | <5% ·◆ |
| KERTZNER, ADAM, BRADLEY | PORTFOLIO MANAGER/SENIOR PARTNER | 2019-01 | <5% ·◆ |
| LEE, KAHYEONG, NMN | MANAGING DIRECTOR/CHIEF COMPLIANCE OFFICER/DEPUTY GENERAL COUNSEL | 2017-01 | <5% ·◆ |
| PANTER, LUCY, CLARE | UK MANAGEMENT COMMITTEE | 2019-12 | <5% ·◆ |
| SCHRAGER, ALAN, MARC |
| PORTFOLIO MANAGER/SENIOR PARTNER |
| 2010-01 |
| <5% ·◆ |
| SONMEZ, MUSA | UK MANAGEMENT COMMITTEE | 2019-12 | <5% ·◆ |
| Sidoti, John, Victor James | MANAGING DIRECTOR, DEPUTY GENERAL COUNSEL & CCO - EUROPE; UK MANAGEMENT COMMITTEE | 2025-07 | <5% ·◆ |
| TIERNAN, DECLAN, MARTIN | UK MANAGEMENT COMMITTEE | 2018-02 | <5% ·◆ |
| ZAESKE, MARK, ALAN | CHIEF FINANCIAL OFFICER | 2026-03 | <5% ·◆ |
| OAK HILL ADVISORS (U.K. SERVICES), LIMITEDentity | PARTNER | 2005-06 | 75%+ ·◆ |
| OAK HILL ADVISORS GENPAR, L.P.entity | GENERAL PARTNER | 2005-04 | 25–50% ·◆ |
| OHA GENPAR PRINCIPAL INVESTORS, L.P.entity | LIMITED PARTNER | 2021-12 | 10–25% |
| OMEGA MERGER SUB 3, LLCentity | LIMITED PARTNER | 2021-12 | 10–25% |
| T. ROWE PRICE ASSOCIATES, INC.entity | LIMITED PARTNER | 2021-12 | 10–25% |
| WSI OHA LLCentity | LIMITED PARTNER | 2018-02 | 10–25% |
Direct owners and executive officers as filed on the adviser's Form ADV Schedule A (as-filed titles; ADV updates annually and on material change). This lists officers and 5%+ owners — not necessarily the full portfolio-management team.
Signed this manager's latest 13F (2025-Q3). The filing's authorized signatory — frequently a compliance officer, general counsel, or CFO — not necessarily the portfolio manager or firm leadership.
